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Dendrites and axons can extend dozens to hundreds of centimeters away from the
cell body so that a single neuron can sense and respond to thousands of stimuli.
Thus, for an accurate function of dendrites and axons the neuronal proteome needs
to be asymmetrically distributed within neurons. Protein asymmetry can be achieved
by the transport of the protein itself or the transport of the mRNA that is then
translated at target sites in neuronal processes. The latter transport mechanism implies
local translation of localized mRNAs. The role of local translation in nervous system
(NS) development and maintenance is well established, but recently there is growing
evidence that this mechanism and its deregulation are also relevant in NS pathologies,
including neurodegenerative diseases. For instance, upon pathological signals disease-
related proteins can be locally synthesized in dendrites and axons. Locally synthesized
proteins can exert their effects at or close to the site of translation, or they can be
delivered to distal compartments like the nucleus and induce transcriptional responses
that lead to neurodegeneration, nerve regeneration and other cell-wide responses.
Relevant key players in the process of local protein synthesis are RNA binding
proteins (RBPs), responsible for mRNA transport to neurites. Several neurological and
neurodegenerative disorders, including amyotrophic lateral sclerosis or spinal motor
atrophy, are characterized by mutations in genes encoding for RBPs and consequently
mRNA localization and local translation are impaired. In other diseases changes in the
local mRNA repertoire and altered local protein synthesis have been reported. In this
review, we will discuss how deregulation of localized translation at different levels can
contribute to the development and progression of nervous system pathologies.
Keywords: local translation, RNA localization, RNA binding proteins, mRNA transport, nervous system
pathologies
INTRODUCTION
Neurons are morphologically the most complex cells in the nervous system (NS). They consist
of a soma, from which several processes emerge. The characteristic asymmetric morphology of
neurons allows them to create stable neural circuits. Through their dendrites and axons, neuronal
processes are capable of receiving and integrating incoming signals from presynaptic terminals and
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transmitting them through signaling pathways to give response
to diverse stimuli. The structural and functional asymmetry of
neurons requires the asymmetrical distribution of the neuronal
proteome, which is achieved by the transport of mature proteins
or the transport of transcripts to target compartments in neuronal
processes. In this article, we focus on the latter mechanism
by which localized messenger RNAs (mRNAs) are transformed
into proteins through a process known as local translation or
local protein synthesis (Rangaraju et al., 2017; Holt et al., 2019)
(Figure 1A).
LOCAL TRANSLATION FOR NEURONAL
HOMEOSTASIS
Protein synthesis is an essential mechanism to ensure proper cell
homeostasis. Thereby, RNA translation and protein transport to
subneuronal domains have been the focus of particular concern
for many researchers. Although for years it was thought that
protein synthesis takes place only in the soma, it is now accepted
that the transport of proteins from the soma to target subcellular
regions is not the only way to supply proteins to distal neuronal
processes (Alberts et al., 2002). mRNAs can also be transported
to subcellular domains for their subsequent translation into
proteins. This phenomenon is known as local protein synthesis
(Holt et al., 2019). Taking into consideration that in some
vertebrates dendrites can extend up to a dozen millimeters from
the soma and that axons can measure more than one meter
(Bannister and Larkman, 1995) it is not surprising that local
protein synthesis serves as a means for neuronal processes to
rapidly react to diverse environmental stimuli. This translation
mechanism was first described in 1960 when local synthesis
of acetylcholinesterase in axons was detected using isotopically
labeled amino acids (Koenig and Koelle, 1960). Subsequently,
some other studies were carried out in different species: local
protein synthesis was also observed in isolated axons of the
giant squid (Giuditta et al., 1968) and nerve fibers in goldfish
(Edstrom and Sjostrand, 1969). Ever since, local protein synthesis
has been studied in cells of the NS with a particular emphasis on
neurons. To date, it is known that local translation is involved in
axonal maintenance, guidance and arborization, and it promotes
synapse formation and synaptic plasticity (Zhang and Poo, 2002;
Martin, 2004; Yoon et al., 2012; Leal et al., 2014). Given that
neuronal processes might as well receive environmental stimuli
with potential detrimental effects, local protein synthesis also
becomes relevant upon neuronal damage and in response to
stress as previously reviewed (Baleriola and Hengst, 2015; Lin
et al., 2020).
Although the local synthesis of acetylcholinesterase in axons
was discovered by Koenig and Koelle (1960) it took two
decades to detect the presence of ribosomes in neuronal
peripheral processes: in 1982 polyribosomes (or polysomes)
were detected for the first time in dendritic spines of
neurons located in the dentate gyrus (Steward and Levy, 1982;
Steward and Fass, 1983) and later, in 1986 polysomes were
detected in axons (Steward and Ribak, 1986). The discovery
of dendritic polysomes encouraged researchers to focus on
mRNA localization and localized translation in dendrites, and
soon various dendritic transcripts were identified, such as
microtubule-associated protein 2 (Map2a) (Garner and Matus,
1988), calcium/calmodulin- dependent protein kinase 2 alpha
(Camk2α) (Burgin et al., 1990) or activity-regulated cytoskeleton-
associated protein (Arc) (Steward et al., 1998), among others.
Actb was the first transcript identified in vertebrate axons (Bassell
et al., 1998) and its translation in Xenopus embryos is involved in
growth cone behavior during development. Other cytoskeleton-
and membrane-associated proteins have more recently been
identified as locally produced in rodent axons (e.g., RhoA, Par3,
and SNAP25. . .) (Wu et al., 2005; Hengst et al., 2009; Batista
et al., 2017). Transcripts encoding proteins associated with
cytoskeleton and membrane dynamics are not the only locally
translated in neuronal processes. Local production of proteins
involved in mitochondrial function and even transcription
factors have been detected in both dendrites and axons as recently
reviewed by Blanco-Urrejola and colleagues (Blanco-Urrejola
et al., 2021). In essence, local translation is a crucial mechanism
that contributes to many neuronal functions and although this
phenomenon has been mainly studied in physiological conditions
it is now accepted that its deregulation is involved in various
neurological diseases (Khalil et al., 2018), which we will review in
this article. However, before we delve into local translation in NS
pathologies, we will briefly describe the process that transcripts
follow since leaving the nucleus until they get translated in target
subcellular compartments.
LOCAL TRANSLATION: FROM mRNA
TRANSPORT TO PROTEIN SYNTHESIS
The canonical view of protein synthesis is that mRNA translation
occurs in the soma either by ribosomes associated to the
rough endoplasmic reticulum (RER) (Figure 1Bi) or by free
ribosomes present in the cytosol (Figure 1Bii). The newly
synthesized proteins are then processed and once mature they
are transported through microtubules by dyneins and kinesins
to different subneuronal domains (Figure 1Ci), where they
carry out their function (Figure 1Di). Conversely, local protein
synthesis requires transcripts to leave the nucleus and bind
ribonucleoprotein (RNP) granules (Figure 1Biii). RNP granules
are then transported to target compartments (Figures 1Cii,iii) and
once there, mRNAs are translated into protein (Figure 1Dii).
mRNA Transport to Neuronal Peripheral
Processes
When mRNAs exit the nucleus, RNA binding proteins (RBPs)
recognize specific localization elements typically found in the
3′-Untranslated Regions (3′-UTR) of the transcripts known as
zip codes (Perry and Fainzilber, 2011; Szostak and Gebauer,
2013; Berkovits and Mayr, 2015). Interestingly, evidence
suggest that long 3′-UTRs provide a longer life span to
RNAs favoring their long distance transport and hence their
localization to peripheral neuronal processes (Tushev et al.,
2018). Besides binding the transcripts, RBPs associate with
translation regulators including ribosomal proteins and other
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FIGURE 1 | Protein and RNA transport to peripheral subneuronal compartments. Roughly it is underlined the neuronal compartments where local protein synthesis
occurs (A). In the soma, expressly in the nucleus, DNA is transcribed to RNA and after splicing, the resulting mRNA (B) can be either processed by the classical
somatic translation or the local protein synthesis. For the classical one, the mRNA is translated by ribosomes associated to RER (Bi) and free cytosolic ribosomes
(Bii). Synthetized proteins are transported (C) through dyneins or kinesis associated to microtubules (Ci) to target compartments where elicit their function (Di). For
local translation, mRNA is associated to RBPs and assembled as RNP granules (Biii), which can be transported through kinesis (Cii) or by myosins linked to actin
filaments (Ciii). At the target compartments (D), transported mRNAs are locally translated, and the newly synthesized proteins (Dii) elicit their function.
components of the translation machinery, ribosomal RNAs,
and non-coding RNAs (Kim et al., 2005; Skup, 2008), and
assemble into membraneless RNPs (Formicola et al., 2019;
Pushpalatha and Besse, 2019; Figure 1Biii). RNPs bind to motor
proteins directly or indirectly via adapters and the transport of
the transcripts to distal compartments is initiated. Depending
on the target compartment, transport occurs via microtubules
bound to kinesins (in the case of axons and dendrites) (Dixit
et al., 2008; Guillaud et al., 2020; Figure 1Cii) or through
actin microfilaments associated to myosin (in axonal growth
cone, presynaptic terminals and dendritic spines) (Hirokawa
et al., 2010; Shirao and Gonzalez-Billault, 2013; Craig, 2018;
Figure 1Ciii). During transport, RNP granules participate in the
repression of translation but they are also involved in the local
translation of proteins when remodeling of the RNP granules
occurs driven by external signals. Interestingly, recent evidence
indicates that RNP granules bind to membranous organelles
located in axons such as endosomes and mitochondria, which
serve as platforms to aid with local protein synthesis (Baumann
et al., 2014; Cioni et al., 2019).
Local Protein Synthesis in Subcellular
Compartments
As in the soma, the ribosomes are the molecular machines
responsible for protein synthesis in subcellular domains. For
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FIGURE 2 | Techniques to detect newly synthesized proteins. (A) Metabolic labeling. Bioorthogonal non-canonical amino acid tagging (BONCAT) and fluorescent
non-canonical amino acid techniques (FUNCAT) are based on non-canonical methionine derivates (an azide or an alkaline) and therefore, they are able to get
incorporated to the nascent protein as methionine through endogenous methyionil-transfer RNA (tRNA) synthetase. The newly synthesized proteins will be labeled
with azide or alkyne groups. For their detection, exogenous reactive groups are then incorporated to azide or alkyne groups: biotin in BONCAT and a fluorescence
protein in FUNCAT. For stable isotope labeling using amino acids in cell culture (SILAC), lysine and arginine are isotopically labeled with 12C (light amino acids) and
13C (heavy amino acids). The incorporation of labeled amino acids allows them to enter into newly synthesized proteins and be detected by mass spectrometry.
(B) Puromycilation. Puromycin is an antibiotic that structurally mimics tRNAs so it can get incorporated into the nascent polypeptide chain and elongation is stopped.
Puromycilated-proteins can be detected by immunochemistry directly using an anti-puromycin antibody for surface sensing of translation technique (SUNSET) or
indirectly when puromycin is bound to biotin for puromycin-associated nascent chain proteomics (PUNCH-P). (C) Ribosome immunoprecipitation-sequencing
(IP-Seq). Translating ribosome affinity purification (TRAP) method consists on labeling ribosomal subunits with Green Fluorescence Protein (GFP) followed by
immunoprecipitation approach. Transcripts bound to ribosomes containing GFP will be isolated and sequenced by RNA-sequencing. Ribo-Seq technique is based
on sequencing all mRNA transcripts which are associated to ribosomes.
many years it was assumed that ribosomes were translationally
active when associated forming polysomes, as these structures
where the first detected in dendrites and axons (Steward and
Levy, 1982; Steward and Fass, 1983; Steward and Ribak, 1986).
However, a recent study has published the existence of both
polysomes and monosomes in synaptosomes. This same study
suggests that while in the soma the vast majority of transcripts
associate to polyribosomes, most synaptic mRNAs bind to and are
translated by monosomes compared to a few synaptic transcripts
that preferentially bind polysomes (Biever et al., 2020).
Local translation, like any other cellular process, requires
energy. Recently, Rangaraju et al. (2019) described that
mitochondrial compartments present in dendrites contribute to
synaptic plasticity by supplying the energy required to synthesize
proteins in spines. However, some subneuronal domains (e.g.,
the presynaptic terminals) do not contain mitochondria and the
energy demands are met by local ATP produced by synaptic
cycles in response to neuronal activity (Rangaraju et al., 2014).
Independently on how subcellular compartments provide the
necessary energy for protein synthesis, transcripts are considered
locally translated if they meet the following requirements: (1)
coding transcripts to be translated need to colocalize with
ribosomes and other components of the translation machinery in
a given subcellular domain, (2) newly synthesized proteins need
to be detected at subcellular levels by techniques such as protein
metabolic labeling (Figure 2A), puromycilation of nascent
peptides (Figure 2B) or ribosome immunoprecipitation followed
by sequencing (Figure 2C), and (3) levels of newly synthesized
proteins need to drop when blocking protein synthesis (e.g.,
with pharmacological inhibitors such as anisomycin or emetine)
(Holt et al., 2019).
LOCAL TRANSLATION IN NERVOUS
SYSTEM PATHOLOGIES
Since the study of the first proteins synthesized in different
subneuronal domains, most research has focused on discovering
new localized transcripts in neurons. However, there was no
evidence linking local synthesis deregulation with neuronal
pathologies until 2001 when Zheng and colleagues described
that intra-axonal RNA translation was activated in response
to nerve injury (Zheng et al., 2001). From then on, there is
growing evidence on the translation of localized transcripts upon
nerve injury and on the role of locally produced proteins in
the response of neurons to damage. For instance, the axonal
synthesis of the transcription factors STAT3 and PPARγ after
sciatic nerve crush is followed by their retrograde transport
toward the neuronal cell body. Once there, both STAT3 and
PPARγ trigger transcriptional programs contributing to nerve
regeneration (Ben-Yaakov et al., 2012). Interestingly, at least
one component of the importin α/β complex required for
retrograde transport is also synthesized in injured axons (Hanz
et al., 2003). These data point at the implication of local
Frontiers in Integrative Neuroscience | www.frontiersin.org 4 June 2021 | Volume 15 | Article 689208
fnint-15-689208 June 24, 2021 Time: 18:18 # 5
Gamarra et al. Local Translation in Disease
translation in neuronal survival following nerve lesions in the
peripheral nervous system. In addition, a deregulation of local
protein synthesis upon damage was also recently suggested in
the central nervous system. In retinal ganglion cells, the RBP
RBPMS is expressed exclusively in the soma but upon hypoxia
and axotomy, RBPMS is redistributed to dendrites and axons,
respectively (Pereiro et al., 2020). Authors have also identified
alterations of various RBPs in different neurological diseases,
including amyotrophic lateral sclerosis, frontotemporal dementia
or spinal muscular atrophy. Likewise, in other disorders such as
Alzheimer’s disease, deregulation of translation of certain mRNAs
in neuronal processes seems to contribute to the pathology. We
will now summarize the current knowledge on how deregulation
of local protein synthesis at different levels can contribute to the
development and progression of NS pathologies (Table 1).
Amyotrophic Lateral Sclerosis (ALS) and
Frontotemporal Dementia (FTD)
Amyotrophic lateral sclerosis is the most common motor neuron
disease with an adult onset and it is characterized by the
degeneration of upper and lower motor neurons. Most of ALS
patients –around 90%– suffer the sporadic form of the disease
whereas the remaining 10% of the cases correspond to familial
ALS with a genetic inheritance (Scotter et al., 2015). Different
genes have been associated to ALS pathology including those
encoding for Cu-Zn superoxide dismutase 1 (SOD1), Tar DNA
binding-protein 43 (TDP-43), fused in sarcoma/translocated in
liposarcoma (FUS), or chromosome 9 open reading frame 72
(C9orf72). Interestingly, some of the ALS-linked genes have
also been related to FTD. FTD is a group of disorders whose
main feature is the loss of neurons in frontal and temporal
brain lobes leading to cognitive impairment. Similarly to ALS,
FTD is mainly a sporadic disorder although 40% of cases have
family history with a 10% of autosomal dominant inheritance
(Bott et al., 2014). In this section we will review the ALS/FTD-
associated genes involved in mRNA localization and translation
within neurites.
Tar DNA binding-protein-43 is an RBP involved in mRNA
splicing, transport and translation in neuronal processes. The
presence of TDP-43 aggregates in the cell cytoplasm in ALS
and FTD patients has been reported. TDP-43 associates to
specific mRNAs in RNP granules and transports them to the
target neuronal compartment where mRNAs can be translated
by the localized translation machinery (Alami et al., 2014).
In 2014, futsch mRNA was identified as a TDP-43 target in
a Drosophila ALS model. Futsch is known to be involved in
the development and maintenance of synaptic contacts at the
neuromuscular junctions (NMJ). Mutant TDP-43 alters futsch
localization: mRNA levels are significantly reduced at the NMJ
while higher levels are detected in neuronal somata. In addition
to mislocalization, TDP-43 also regulates futsch translation
by shifting mRNA from actively translating polysomes to
non-translating ribonuclear protein particles. Similarly, the
mammalian homolog of Futsch, MAP1B accumulates in motor
neuron cell bodies in the spinal cord from ALS patients (Coyne
et al., 2014). As both Futsch and MAP1B are part of the
microtubule cytoskeleton, defects in their local translation due to
mutant TDP-43 could lead to cytoskeletal defects, contributing to
ALS development (as summarized in Figure 3A).
Another important RBP linked to ALS and FTD is FUS,
which, as TDP-43, plays a role in RNA metabolism (splicing,
trafficking and translation). FUS also appears in cytoplasmic
inclusions in diseases. However, it was reported that FUS deposits
are post-translationally modified by arginine unmethylation
only in postmortem tissue from FTD patients but not in ALS
ones. Indeed, FUS hypomethylation triggers its aggregation and
consequently alters RNP granules and local protein synthesis
in neurites (Qamar et al., 2018). On the other hand, wild
type FUS is present in somata and along neuronal processes
as well, including dendrites, spines and the NMJ. Specifically,
FUS has been detected at translation sites in axons. ALS-
linked mutations in FUS lead to its accumulation in neurites
of hippocampal and sciatic nerve neurons. Moreover, mutant
FUS leads to stress-mediated inhibition of intra-axonal protein
synthesis and therefore to synaptic dysfunction (Lopez-Erauskin
et al., 2018; Figure 3A). In fact, a previous study had already
reported the incorporation of cytoplasmic mutant FUS into stress
granules (Bosco et al., 2010). Some FUS target mRNAs are
abnormally expressed when FUS is mutated. For instance, Fos-
B is upregulated in axons in FUS-mutant motor neurons causing
an increase in axonal branching. The axonal morphology can be
rescued by the suppression of exacerbated Fos-B expression by
locally applying siRNAs to axons. Interestingly, an abnormal Fos-
B upregulation in ventral horn neurons in ALS autopsy samples
has also been reported (Akiyama et al., 2019).
In addition to the contribution to intra-axonal translation,
both FUS and TDP-43 are also localized to dendrites and
dendritic spines (Swanger and Bassell, 2013). Furthermore, TDP-
43 does not only regulate mRNA translation but is also involved
in dendritic mRNA trafficking (Chu et al., 2019).
Notably, an interaction between FUS and TDP-43 was
identified in 2010. It is of interest to highlight that this
FUS/TDP-43 association is enhanced by ALS-linked mutant
variants in TDP-43 (Ling et al., 2010). Therefore, this report
reveals the possible convergence of pathogenic mechanisms from
both FUS and TDP-43 in ALS. Similarly, other interactions
between proteins associated to NS disorders have been identified.
TDP-43 seems to interact to disrupted in schizophrenia 1
(DISC1) in brains of both FTD mouse model and patients.
The TDP-43/DISC1 complex negatively regulates dendritic local
translation in response to neuronal activity. This association
might explain some psychiatric behaviors observed in FTD
patients since DISC1 is a relevant player in the pathology of
psychiatric disorders (Endo et al., 2018). In the case of FUS,
it interacts with the survival motor neuron protein (SMN), the
main responsible for the development of spinal muscular atrophy
(SMA). The relationship between both disease-linked proteins
will be discussed in the next paragraph corresponding to SMA.
The GGGGCC repeat expansion in the C9orf72 gene
is associated to a significant percentage of familial ALS
cases. Although C9orf72 function remains unclear, authors
have demonstrated that the repeat expansion can form
G-quadruplexes, which are known to participate in splicing,
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TABLE 1 | Summary of altered proteins and mRNAs involved in local translation in different nervous system pathologies.
Disease Protein/mRNA Altered mechanism on local
translation
Model system References
ALS/FTD TDP-43 Abnormal trafficking of futsch/Map1b
mRNAs to neurites leading to
cytoskeleton defects
Drosophila model of ALS in vivo, ALS
vs. control postmortem brain tissue
Coyne et al., 2014
FUS Stress-mediated inhibition of
intra-axonal translation
HEK-293 cell line and zebrafish embryo
spinal cords; mutant FUS mice and
mouse hippocampal neuron culture
Bosco et al., 2010; Lopez-Erauskin
et al., 2018
C9orf72 mRNP granules mislocalization to
neuritic compartments affecting to
branching
Rat spinal cord neuron culture,
Drosophila model in vivo
Burguete et al., 2015
SMA SMN Actb, Nrn1, Gap43, Anxa2
mislocalization altering neurite growth,
presynaptic function, and cytoskeleton
Repression of axonal mTOR through
miR-183
NSC-34 cell line; mouse motor neuron
culture
Rat hippocampal, cortical, and motor
neuron culture
Rage et al., 2013; Fallini et al., 2014,
2016; Kye et al., 2014; Rihan et al.,
2017
AD Mapt Mapt mislocalization to dendrites and
hyperphosphorylation
Mouse hippocampal neuron culture,
WT vs. Tau KO mice; hippocampal
neuron culture from WT and Fyn KO
mice, HEK-293 cell line, WT, APP23
and FynCA Tg mouse models in vivo
Kobayashi et al., 2017; Li and Gotz,
2017
Atf4 Atf4 recruitment to axons induced by
Aβ oligomers, leading to neuronal death
Rat hippocampal neuron culture,
mouse model in vivo, AD and control
postmortem human brain tissue
Baleriola et al., 2014; Walker et al.,
2018
PD UPR genes UPR altered.
A compartment-dependent UPR
involving local translation?
α-synuclein Tg mice Hetz and Saxena, 2017
LRRK2 Deregulation of global eIF4E/4E-BP.
Defects in axonal 4E-BP dependent
translation?
Axonal microRNAs deregulation?
HEK-293 and SH-SY5Y cell lines; rat
superior cervical ganglia neuron culture;
rat cortical neuron culture, WTvs.
LRRK2 KO mice
Imai et al., 2008; Kumar et al., 2010;
Natera-Naranjo et al., 2010; Herzig
et al., 2011; Trancikova et al., 2012
PINK1/PARK2 Pumilio and Glorund/hnRNP-F
displacement: altered translation in the
mitochondrion surface (within axons?)
due to PINK1/PARK2 mutations.
Drosophila PINK1 model and HEK
293T cell line
Mouton-Liger et al., 2017; Martinez
et al., 2019
HD HTT Impaired dendritic levels of Actb mRNA,
Ago2 protein and P-bodies
Altered axonal BDNF delivery leading to
neurotoxicity
Homozygous Htt mutant cell lines
(109Q/109Q); HeLa S3 cells
Flagged-Htt590; rat cortical neuron
culture and brain sections
Gauthier et al., 2004; Savas et al.,
2008; Ma et al., 2010, 2011; Savas
et al., 2010
ASD and FXS FMRP Deregulation of local mRNAs linked to
abnormal spine morphology and
plasticity
Upregulation of dendritic Dlg4
translation through inhibition of
miR-125a with spine morphology
defects
Dendritic mTOR upregulation
Rat hippocampal neuron culture;
cortical neuron culture from Fmr1 KO
mice; in vivo Fmr1 KO mouse model;
Organotypic hippocampal slice cultures
from Fmr1 KO mice
Antar et al., 2004; Muddashetty et al.,
2011; Pyronneau et al., 2017; Banerjee
et al., 2018; Feuge et al., 2019
DS Dscam Upregulation of dendritic mRNA and
protein levels with defects in dendrite
branching
Mouse hippocampal neuron culture
from Ts1Cje mice, DS mouse model
Alves-Sampaio et al., 2010
Bdnf Upregulation within dendrites leading to
an aberrant activation of dendritic
translation
In vitro hippocampal dendrites from
Ts1Cje mice





Dendritic Bdnf localization to dendrites
disrupted
Ts1 Cje mouse hippocampal neuron
culture
Swanger and Bassell, 2013
Pumilio-2 (epilepsy) Erroneous mRNAs localization to axons
Upregulation of overall translation in
axons with branching defects
In vivo 5 month Pum2 gene-trap mice;
Pum2 knockdown in primary dorsal
root ganglion rat neuron culture and
mouse model in vivo
Follwaczny et al., 2017; Martinez et al.,
2019
ALS, amyotrophic lateral sclerosis; FTD, frontotemporal dementia; SMA, spinal muscular atrophy; AD, Alzheimer’s disease; PD, Parkinson’s disease; HD, Huntington’s
disease; ASD, autism spectrum disorders; FXS, fragile-X syndrome; DS: down syndrome.
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FIGURE 3 | Local translation defects in ALS/FTD and SMN. (A) Among ALS/FTD-linked proteins, TDP-43, FUS, and C9orf72 are found. The RBPs TDP-43 and FUS
play a role in RNA metabolism. The aggregates usually found in ALS and FTD patients impair TDP-43 and FUS function leading to altered mRNA localization and the
consequent cytoskeletal deregulation and stress-mediated intra-axonal translation inhibition, respectively. The GGGCC repeat expansion in the C9orf72 mRNA
triggers its assembly in RNP granules, which are erroneously localized to neuritic compartments and affect to nerve branching. (B) Loss of SMN is the main cause of
SMA. SMN is involved in the localization of mRNAs to the axonal compartment. SMN defects lead to Actb, Nrn1, Gap43, and Anxa2 mislocalization with important
impact in neurite growth, presynaptic function, and cytoskeleton plasticity. SMN also controls the regulator of local translation mTOR through miR-183. *PD miRNAs
are also involved in the translation repression induced by mutant LRRK2 in PD. Due to local miRNAs have been identified as contributors to other pathologies, a
similar local mechanism could participate in the pathogenesis of PD.
mRNA trafficking and translation regulation (Fratta et al.,
2012). In addition, GGGGCC repeat RNAs are assembled
into mRNA transport granules and wrongly localized to
neuritic compartments. The consequent mislocalization of
mRNA granules alters nerve branching (Figure 3A). These
observations suggest a novel mechanism underlying neuronal
defects in disease-associated expanded repeats like ALS
(Burguete et al., 2015).
As mentioned above, late endosomes act as platforms for
local protein synthesis in axons and dendrites. Moreover,
other organelles, including mitochondria or lysosomes, can be
“vehicles” for RNP granule transport and localization. ANXA11
is an RNA granule-associated protein that acts as an adaptor
between lysosomes and RNP granules. ALS-associated mutations
in ANXA11 prevents RNP granule association to lysosomes and
impaired RNP transport which results in altered RNA localization
to axons what might contribute to axonal degeneration in ALS
(Liao et al., 2019).
Together, these findings underline the relevance of a correct
localization of mRNAs for neuronal physiology: while mutant
forms of the RBPs TDP-43 and FUS alter localization of certain
mRNAs within neurites and lead to the consequent impairment
on cytoskeleton and synapses, the defective localization of mRNA
granules in neurites caused by the GGGGCC repeat expansion in
C9orf72 results in altered branching (Figure 3A and Table 1).
Spinal Muscular Atrophy (SMA)
Spinal muscular atrophy is another example of a motor
neuron disease in which both RBP deregulation and mRNA
mislocalization have been reported. SMA is an autosomal
disorder characterized by the progressive loss of spinal motor
neurons and skeletal muscle atrophy. Mutations in the SMN1
gene leading to reduced SMN levels haven been identified as the
cause of SMA pathology. SMN is a ubiquitously expressed RBP
whose main function is the assembly of small nuclear RNPs for
mRNA splicing. However, neuronal SMN is also involved in the
assembly of RNP complexes required for mRNA transport to
axons and for local translation. Fallini and colleagues described
that the association of SMN to messenger RBPs (mRBPs) such
as HuD and IMP1 is involved in the localization of poly(A)
mRNAs to the axonal compartment (Fallini et al., 2011, 2014).
Defects in axonal SMN thus lead to mRNA mislocalization.
Among mislocalized mRNAs, some relevant for neurite growth
and presynaptic function can be found, including Actb, Nrn1,
and Gap43, to mention but a few. For instance, Gap43 is
reduced in growth cones of SMA motor neurons at mRNA
and protein levels. Interestingly, HuD and IMP1, both of them
altered by defects in SMN, control the transport of Gap43 mRNA.
Conversely, the overexpression of these mRBPs is sufficient to
restore axon growth (Fallini et al., 2016). Likewise, 50% of
SMN reduction impairs the localization of other mRNAs such
as Anxa2 (encoding Annexin A2) and Cox4i2 (Rage et al.,
2013). Annexin A2 is involved in actin cytoskeleton plasticity.
The observed defects in cytoskeleton organization in SMN
deficiency models could be explained at least in part by the
mislocalization of Anxa2 and its consequent impaired axonal
translation (Rihan et al., 2017). Altogether, these data suggest
that deregulation of mRNA localization to axonal compartments
and local protein synthesis are key players in the development
of SMA pathology.
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Survival motor neuron protein also controls local translation
through microRNA (miR) expression. In SMN-deficient neurons,
miR-183 is increased in neurites. miR-183 targets axonal
mTOR, a master regulator of local protein synthesis, leading
to reduction of its own translation. Therefore, overall mTOR-
dependent local translation is decreased in SMN-deficient axons
(Kye et al., 2014).
We have mentioned in previous paragraphs the existent
interaction between proteins associated to different
neurodegenerative diseases. A 2013 study identified FUS,
one of the ALS/FTD-linked RBPs, as an interactor of SMN. The
association between both RBPs appears to be influenced by FUS
mutations and leads to a redistribution of SMN toward FUS
deposits with the consequent impairment in axonal localization
of SMN (Groen et al., 2013). Moreover, there is evidence of the
association of SMN and FMRP (fragile X mental retardation
protein, involved in Fragile X syndrome) in neuronal mRNP
granules (Piazzon et al., 2008).
To summarize, SMN contributes to local protein synthesis
regulation through its interaction with RBPs and the control of
miRNAs. Therefore, mutations in this protein result in mRNA
mislocalization and repression of axonal translation (Table 1).
The data reviewed so far overall suggest that dysfunction of
RBPs and the consequent mRNA mislocalization alter localized
translation and underly the pathophysiological features of motor
neuron diseases as depicted in Figure 3B.
Alzheimer’s Disease (AD)
Alzheimer’s disease is the most common cause of dementia
among the elderly. It is an incurable neurodegenerative disease
characterized by the gradual loss of cognitive and functional
abilities. Pathological cellular dysfunction in AD begins many
years before the onset of the symptoms. Two hallmarks have
been identified in postmortem brains as main contributors
to AD pathology: the neurofibrillary tangles, composed of
hyperphosphorylated microtubule associated protein Tau
(MAPT or Tau) and the extracellular β-amyloid (Aβ) plaques
(Tiwari et al., 2019; Busche and Hyman, 2020). Although the
mechanisms leading to the development and spread of the
disease through the brain are not fully understood, it is known
that synapse loss is one of the first pathological signs of AD
(Selkoe, 2002). Alterations in the axonal and dendritic proteomes
could underlie synaptic dysfunction and thereby the study of
local protein synthesis in this context might provide clearer
knowledge on the development of the disease.
Tau is mainly localized to axons though is also present in
the somatodendritic compartment at very low levels in healthy
neurons (Tashiro et al., 1997). Axonal Tau is partially the
product of locally translated Mapt mRNA (Aronov et al., 2001;
Gauthier-Kemper et al., 2018). Nevertheless, Mapt gets aberrantly
localized to dendrites in tauopathies such as AD. For instance,
Aβ peptides induce Mapt mRNA localization to dendrites and
its localized translation. Intriguingly, the mislocalization and
dendritic synthesis of Tau enhances its hyperphosphorylation
(Kobayashi et al., 2017; Li and Gotz, 2017), indicating that
Tau synthesis in the inappropriate subneuronal compartment
contributes to neurodegenerative diseases such as AD.
Aβ peptides are the result of incorrect proteolytic cleavage
of amyloid precursor protein (APP) and are prone to
aggregate, which results in the formation of senile plaques
(Rabbito et al., 2020). We have stated that Aβ triggers Tau
synthesis in dendrites but it also induces local protein synthesis
in axons (Baleriola et al., 2014; Gamarra et al., 2020). The mRNA
encoding the transcription factor ATF4 (previously known
as CREB2) is among the proteins whose local translation is
induced by Aβ peptides. Interestingly, axonally synthesized
ATF4 is retrogradely transported to the nucleus where it alters
transcription leading to neuronal death both in vitro and in vivo
(Baleriola et al., 2014; Figure 4A). Additionally, Atf4 recruitment
to Aβ-exposed axons is itself triggered by local translation
of sentinel mRNAs such as the intermediate filament protein
vimentin (Vim) (Walker et al., 2018). These studies suggest a
common axon-to-soma communication mechanism in injured
nerves and in response to amyloid based on axonally synthesized
transcription factors although the outcome of the transcriptional
response differs: a regenerative response of injured nerves vs.
neuronal death following the local exposure to Aβ oligomers.
Atf4 is not the only mRNA found in Aβ-treated axons.
Interestingly, transcripts from 9 of the 20 susceptibility genes
associated to late onset AD are axonally localized following
exposure to Aβ oligomers: App, Clu, ApoE, Sorl1, Bin1, Picalm,
Ptk2, Celf1, and Fermt2 (Blanco-Urrejola et al., 2021).
Local translation has also been described in other neural
cells like oligodendrocytes. For example, the heterogeneous
nuclear RNP A2 (hnRNP A2) is part of the transport granules
responsible for mRNA localization to peripheral processes in
oligodendrocytes (Hoek et al., 1998; Munro et al., 1999).
Intriguingly, loss of hnRNP A/B in entorhinal cortices from AD
brains has been reported. Experiments performed in neurons
indicate that defects in hnRNP A/B lead to dendritic loss
in vitro and memory and electrocorticographic alterations
in vivo (Berson et al., 2012). Based on the role of hnRNP
A2 in oligodendrocytes a possible involvement of hnRNP A/B
in neuronal mRNA metabolism cannot be discarded. Further
investigation should be carried out in order to fully understand
the role of hnRNPs in RNA localization and protein synthesis in
neuronal processes in disease.
Regarding interaction between proteins associated to different
NS pathologies, in 50% of FTD cases an accumulation of Tau
fibrils has been observed (Goedert et al., 2012). Interestingly,
reduced levels of the ALS/FTD-linked TDP-43 are detected in
the AD brain. Indeed, TDP-43 promotes Mapt mRNA instability
through its 3′-UTR, suggesting that altered TDP-43 might
contribute to Tau aggregation (Gu et al., 2017). Taking into
account that axonal localization signals are usually located at
the 3′-UTR, we can speculate that deregulation of TDP-43 also
affects Tau localization and therefore might also contribute to Tau
pathology in FTD.
Results reviewed in these paragraphs strongly point toward
the importance of mRNA localization and localized translation
and/or deregulation of both phenomena in the development of
AD and related disorders. One of the main hallmark of AD,
Aβ aggregates, lead to deregulation of local protein synthesis
in both dendrites and axons. These events contribute to Tau
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FIGURE 4 | Local translation defects in AD and HD. (A) The two main hallmarks in AD brains are the accumulation of intracellular hyperphosphorylated Tau and
extracellular Aβ plaques. Aβ induces the incorrect localization of Mapt mRNA to dendrites with the consequent, local synthesis of Tau and its hyperphosphorylation
(1). Aβ also induces the recruitment of certain mRNAs to axons, among them Atf4 is found (2). Once ATF4 is axonally synthesized (3), it is retrogradely transported to
cell body (4) where enhances death transcriptional programs (5). *PD ATF4 is also a component of UPR. The UPR is altered in PD and therefore the local ATF4 could
be involved in PD progression. (B) HD is caused by a mutant CAG expansion in HTT gene. HTT KO leads to reduced levels of Actb mRNA, Ago2 protein, and
p-bodies in dendrites. Mutant HTT impairs BDNF transport to axons resulting in neurotoxicity and probably affects to local protein synthesis since BDNF regulate this
process in subneuronal compartments.
hyperphosphorylation and neuronal death respectively (Table 1).
Thus, restoring levels of localized mRNAs and/or their localized
translation could alleviate cell dysfunction linked to AD.
Huntington’s Disease (HD)
Huntingtin (HTT) is a protein expressed at high levels
in several brain regions like the hippocampus, the cortex,
the cerebellum and the striatum. CAG repeat expansions
in the HTT gene result in a repeated polyQ tract in the
N-terminal region of the HTT protein, causing HD. HD is
an autosomal dominant neurodegenerative disease characterized
by uncontrolled movements, and behavior and cognitive
impairments (Landles and Bates, 2004; Li and Li, 2004). HTT, as
well as APP, is transported along axons and has been implicated
in dendritic RNA delivery (Ma et al., 2010; Savas et al., 2010).
Importantly, HTT inactivation leads to impaired localization
of RNAs and membranous organelles (Gauthier et al., 2004),
indicating that HTT plays an important role in RNA transport.
Similar to other previously mentioned neurodegenerative
disorders, RBPs colocalize with the main driver of HD: HTT
interacts with Ago2 and Staufen in processing bodies (P bodies)
which contain translationally repressed mRNAs (Savas et al.,
2008), and in dendritic RNA granules involved in transport
and local translation (Savas et al., 2010). Additionally, HTT
was reported to bind to the 3′-UTR of dendritically targeted
mRNAs including Ip3r1, Actb, and Bdnf. Moreover, HTT
knockout (KO) reduces levels of dendritic Actb mRNA, Ago2
protein, and P bodies (Ma et al., 2010, 2011; Savas et al.,
2010). HTT is also required for BDNF vesicular transport along
microtubules toward the axons. Mutant HTT impairs BDNF
transport leading to neurotoxicity (Gauthier et al., 2004) (as
summarized in Figure 4B). Noteworthy, BDNF is known to
regulate local translation (Swanger and Bassell, 2013) and thus
local protein synthesis in HD might be impaired via defective
axonal BDNF delivery.
Huntingtin is thus yet another example of a main contributor
to NS pathology involved in mRNA trafficking to neuronal
processes by its interaction with RBPs or by its direct binding to
mRNA 3′-UTRs (Table 1).
Parkinson’s Disease (PD)
Parkinson’s disease is a chronic neurodegenerative disorder
in which dopaminergic neurons of the substantia nigra
progressively die and there is an accumulation of Lewy bodies
composed of abnormal intracellular aggregates of alpha synuclein
protein (αSyn) and ubiquitin (Goedert et al., 2013). The
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pathogenic process in PD involves regions of the central and
peripheral NS with bradykinesia, rigidity and other motor
symptoms being the main clinical manifestations (Halliday
and McCann, 2010). As in AD, pathological signs at cellular
levels appear before clinical symptoms and lead to the loss
of 60-70% of neurons in the substantia nigra pars compacta
(Radhakrishnan and Goyal, 2018).
Impairment of local protein synthesis in PD has not been
fully demonstrated. However, a recent review by Lin and
colleagues commented on this possibility. Given their complex
morphology, neurons cope with stress in a compartmentalized
manner (Lin et al., 2020). In PD, as in AD, prion disease
and other disorders in which protein aggregation occurs,
stress responses in neurons are evident before the pathological
hallmarks of the disease are apparent. Oxidative stress and
ER stress induce mechanisms able to cope with basal levels
of neuronal damage. However, when a certain threshold
is reached, those same mechanisms might backfire and
contribute to neurodegeneration. Interestingly, the dual role and
compartmentalized nature of stress mechanisms was implicitly
reported in a mouse model of acute amyloid pathology where
locally translated ATF4 mediates neurodegeneration while global
increases of this same transcription factor allows neurons to
adapt to Aβ-induced stress (Baleriola et al., 2014). ATF4 is
an important component of the unfolded protein response
(UPR). The UPR involves a global shutdown of protein synthesis
via eIf2α while promoting translation of mRNAs encoding
stress-related proteins. ATF4 is classically synthesized upon
accumulation of unfolded and misfolded proteins and the
consequent UPR activation due to ER stress. However, in
Aβ-treated axons, ATF4 translation (likely via eIf2α) but no other
canonical signs of the UPR, such as protein synthesis shutdown,
are apparent. A partial, non-canonical activation of the UPR
has also been observed in developing axons when challenged
with Sema3a (Cagnetta et al., 2019). The UPR is known to be
altered in AD, PD with Lewy bodies, prion disease, HD and
even ALS (Hetz and Saxena, 2017). It would be interesting to
address if in neurodegenerative diseases other than AD, such as
PD, a compartment-dependent UPR involving local translation
contributes to disease progression (Figure 4A).
On the other hand, several studies implicate translation
in PD pathogenesis. Proteins encoded by PD-associated genes
have recently been shown to interact with components of
the translation initiation complex. For instance, Leucine-rich
repeat kinase 2 (LRRK2) whose mutations are involved in
autosomal dominant Parkinson’s disease, phosphorylates 4E-BP,
releasing the repression from the initiation factors eIF4E/eIF4G.
Mutant forms of LRRK2 in Drosophila stimulate eIF4E inducing
aberrantly high protein synthesis accompanied by loss of
dopaminergic neurons (Imai et al., 2008). LRRK2 is also known
to regulate eIF4E/4E-BP in mammals but results seem to be
conflicting. Whereas in vitro experiments indicate increased 4E-
BP phosphorylation induced by LRRK2 (Kumar et al., 2010),
Trancikova and colleagues did not observe any effect on 4E-BP
with in vivo gain- or loss-of-function approaches (Trancikova
et al., 2012). Others, however, have observed increased phospho-
4E-BP levels in LRRK2 KO and LRRK2 kinase dead but not
in knock-in transgenic mice (Herzig et al., 2011). The so far
inconclusive results on the effect of LRRK2 on the eIF4E/4E-BP
axis might be due to the analyses being performed in whole cells
and tissues. It would be interesting to determine whether in PD,
as in Aβ pathology, 4E-BP dependent translation is enhanced in
axons (Baleriola et al., 2014).
Work from Gehrke and colleagues suggested that translation
repression induced by pathogenic LRRK2 is elicited through
repression of miRNAs. Interestingly, miRNAs can be found in
axons (Natera-Naranjo et al., 2010) and as mentioned before
miR-183 regulates axonally synthesized mTOR which in turn
modulates local protein synthesis in SMA (Kye et al., 2014).
It would be worth determining if a similar local mechanism is
involved in the pathogenesis of PD (see ∗PD in Figure 3B).
Mutations in Pten-induced kinase 1 (PINK1/PARK6) or
Parkin (PARK2), which are involved in early-onset autosomal
recessive PD alter mitochondrial function. PINK1 and PARK2
promote mitochondrial localization and translation of specific
mRNAs at the mitochondrial outer membrane (Gehrke
et al., 2015). Translation activation via PINK1 and PARK2
implies the displacement of the repressive RBPs Pumilio and
Glorund/hnRNP-F (Mouton-Liger et al., 2017). Both proteins
influence mitochondrial function and play an important role
in translation. Whether both RBPs play a role in localized
translation in PD remains unknown. Interestingly, however,
Pumilio 2 is known to regulate the local transcriptome of
developing axons (Martinez et al., 2019) (∗PD in Figure 5C).
Although there are so far no concluding remarks on how local
translation could contribute to PD pathogenesis, the fact that
global protein synthesis is likely aberrantly high and that there
are similarities with AD and HD strongly point to the possibility
that RNA localization and localized translation in neurons are
compromised in this disease and might even contribute to
its progression.
Autism Spectrum Disorders (ASD) and
Fragile X Syndrome (FXS)
Autism spectrum disorders is a term referred to heterogeneous
behavioral disorders with a combination of difficulties in
different areas including intellectual, communication or social
interaction. The most common monogenic cause of ASD is
FXS, a neurodevelopmental disorder which causes intellectual
disability attributed to FMRP protein deficiency as a result of a
mutation in the FMR1 gene (Salcedo-Arellano et al., 2020). One
of the main cell-pathological features of FXS is the high levels of
dendritic spines with an abnormal morphology linked to delayed
maturation (Banerjee et al., 2018).
Fragile X mental retardation protein is a well-known RBP
whose implication in dendritic local translation has been widely
studied. FMRP is involved in several steps of local protein
synthesis: from mRNA trafficking to peripheral processes to
ribosome stalling or microRNA regulation. In relation to mRNA
transport, Feuge et al. (2019) described that FMRP binds to
Cof1 mRNA and regulates its localization to and translation
within dendrites. Cof1 encodes cofilin 1, an actin-binding protein
involved in dendritic spine structure and plasticity, and it was
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recently associated with the FXS pathology (Pyronneau et al.,
2017). In Fmr1 KO mice, defects on local Cof1 mRNA were
observed with the consequent plasticity impairment (Feuge et al.,
2019). Additionally, FMRP target mRNAs encoding synaptic
proteins have also been reported, including Arc, Camk2a, Dlg4, or
Map1b. Interestingly, Frm1 mRNA itself is localized to dendrites
(Antar et al., 2004; Banerjee et al., 2018). Hence, the loss of
FMRP leads to mislocalization and altered local translation of
FMRP binding mRNAs, and FMRP deficiency is likely linked
to defects in spine morphology and in neuronal plasticity
observed in FXS.
Besides interacting with target mRNAs, FMRP can also bind
reversibly to ribosomes and paralyzes the elongation phase
of translation (Feng et al., 1997; Darnell et al., 2011; Chen
et al., 2014). Furthermore, deregulated miRNAs were observed
in postmortem brain tissue from ASD patients (Abu-Elneel
et al., 2008). Interestingly, PSD-95 (encoded by Dlg4) local
synthesis in dendritic compartments is mediated by the also
dendritically localized miR-125a in FXS. FMRP is required for
miR-125a activity through the RNA-induced silencing complex
(RISC). Indeed, in Fmr1 KO neurons Dlg4 translation is
increased while miR-125a levels are reduced in Fmr1 KO
synaptoneurosomes, affecting spine morphology and branching
(Muddashetty et al., 2011).
Fragile X mental retardation protein binds ALS/FTD-linked
TDP-43 to regulate the transport of mRNP granules in mouse
dendrites. The association between FMRP and TDP-43 RBPs
in mRNPs trafficking again opens new venues to shed light on
common pathophysiological mechanisms of mRNA localization
and localized translation underlying neurodevelopmental and
neurodegenerative diseases (Chu et al., 2019).
Despite most evidence links FMRP to local translation in
dendrites, FMRP-containing RNP granules have been detected
in developing and mature axons as well (Christie et al., 2009;
Akins et al., 2012, 2017). Additionally, axonal Map1b and Calm1
mRNAs have been identified as miR-181d targets. FMRP appears
to associate with miR-181d and its target mRNAs in dorsal
root ganglion neurons (DRGs) upon nerve growth factor (NGF)
stimulation and regulates axon outgrowth. FMRP deficiency
in vitro and in a FXS mouse model leads to the mislocalization
of miR-181d, Map1b and Calm1 (Wang et al., 2015). Further
research is required on this regard to clarify the involvement of
FMRP in intra-axonal protein synthesis and the more than likely
contribution thereof to FXS pathology.
Finally, FMRP is able to regulate mTOR activity in dendrites.
mTOR is not only considered a regulator of axonal translation
but it is also involved in intra-dendritic protein synthesis. In Fmr1
KO mice and in studies of FXS patients, an upregulation of mTOR
was detected. In addition, mTOR is also altered in other FMRP-
deficiency diseases, such as tuberous sclerosis, Rett syndrome,
and Down syndrome (Hagerman et al., 2010; Wang et al., 2010;
Troca-Marin et al., 2011).
From all the documented evidence gathered in this section it
seems clear that FXS is one of the best examples of the extent
to which deregulation of local mRNA translation contributes
to disease progression. The abnormal morphology of dendritic
spines typically observed in FXS could be explained by the
wide involvement of FMRP in dendritic local protein synthesis.
As summarized in Table 1, FMRP defects entail deregulation
of dendritically localized mRNAs and miRNAs, which results
in spine morphology and plasticity impairment. Furthermore,
dendritic mTOR is also controlled by FMRP. All this knowledge
will allow a better understanding of ASD and will hopefully help
develop new therapeutic strategies (Figure 5A).
Down Syndrome (DS)
Down syndrome is the most common genetic cause of intellectual
disability triggered by trisomy of human chromosome 21.
Neurological symptoms are accompanied by abnormal physical
growth. In some DS cases congenital heart defects are apparent.
Duodenal stenosis or leukemia are also more frequent in DS
patients than in the general population (Antonarakis et al., 2004).
Although the specific mechanisms leading to neurological signs
remain poorly understood, it is known that DS is characterized by
defects in dendrite morphology and synaptic plasticity similarly
to other developmental diseases like FXS (Alves-Sampaio et al.,
2010). The mRNA encoding the DS cell adhesion molecule
(DSCAM) is present in dendrites and DSCAM has been
suggested to play a role in synaptic plasticity. Therefore, altered
Dscam mRNA localization and defects in DSCAM local synthesis
might contribute to DS-related pathogenic features in neurons.
In fact, Dscam mRNA levels as well as its localized translation
are increased within dendrites of hippocampal neurons leading
to a negative effect on dendrite branching in a DS mouse
model (Alves-Sampaio et al., 2010). Additionally, the same
DS model presents increased dendritic levels of BDNF, which
is a local protein synthesis modulator (Swanger and Bassell,
2013). Consequently, the rate of local translation in dendrites is
aberrantly increased (Troca-Marin et al., 2011; Figure 5B).
Other Neurological Disorders
Interestingly, a point mutation in the human BDNF gene is
associated with depression and bipolar disorder. The presence
of the human BDNF mutation in a mouse model disrupts the
localization of Bdnf mRNA to dendrites (Swanger and Bassell,
2013). These data suggest that altered Bdnf localization and
the consequent defects in its translation might contribute to
psychiatric disorders (Figure 5B), although this contribution
should be explored further.
Finally, epilepsy is also associated with deficiencies in RBPs.
For instance, in 2017 Pumilio-2 was described as an RBP involved
in epileptogenesis (Follwaczny et al., 2017). A recent study has
described Pumilio-2 as a regulator of the axonal transcriptome in
developing axons, whose mechanism of action is the exclusion
of RNAs from the axonal compartment by retaining them in
the cell body. Importantly, Pumilio-2 knockdown not only leads
to the erroneous axonal mRNAs localization and increased
overall translation levels in axons, but also to branching defects
(Martinez et al., 2019) as summarized in Figure 5C.
To sum up, increasing evidence suggest that mRNA
localization and local protein synthesis might be a key
contributor to NS pathological conditions, not only in
neurodegenerative diseases but also in other neurological
disorders as discussed in these paragraphs.
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FIGURE 5 | Local translation defects in FXS, DS and epilepsy. (A) The most common monogenic cause of ASD is FXS, caused by a mutation in FMR1 gene with the
consequent FMRP protein deficiency. FMRP regulates RNA metabolism at different levels and therefore, intra-dendritic translation is altered at several points:
mTOR-mediated local protein synthesis is upregulated; deregulation of local mRNAs-linked to FMRP leads to abnormal spine morphology and plasticity;
deregulation of miR-125a induces Dlg4 mRNA dendritic translation with spine morphology defects. (B) DS, caused by trisomy of chromosome 21, is characterized
by defects in dendrite morphology, which can be due to the increased levels of Dscam and Bdnf mRNAs in dendrites. The localization of Bdnf to dendrites is also
disrupted in psychiatric disorders. (C) In epilepsy, deficiency in the RBP Pumilio-2 results in incorrect localization of mRNAs to axons and increased overall
intra-axonal translation with the consequent branching defects. *PD PINK1 and PARK2, involved in PD pathogenesis, regulate translation of mitochondrial proteins
by displacement of Pumilio-2 and other RBPs. Due to the local role of Pumilio-2 in translation in developing axons, localized translation in PD could also be altered.
CONCLUDING REMARKS
The data reviewed in this article bring to light the increasing
body of evidence on the relevance of mRNA localization and local
protein synthesis not only in brain development and physiology
but also in NS pathologies including neurodegenerative diseases
(Table 1). We cannot, however, overlook the limitations
in studying local protein synthesis. While we can separate
different subneuronal compartments in vitro using diverse
specialized culture systems (microfluidic chambers, modified
Boyden chambers. . .), this task cannot be performed in vivo. In
whole animals, neuronal processes are intermingled and cannot
be found in isolation. Even when synaptosomes can be isolated
from entire tissues, thorough controls have to be performed
in order to ensure that RNAs and proteins of interest are
indeed localized to neuronal peripheral domains and/or are a
result of local protein synthesis. Additionally, often times the
amount of material obtained from synaptosomes or brain regions
enriched in neurites (e.g., the neuropil) is limiting. Identification
of specific transcripts and proteins along neuronal processes is
possible also by in situ hybridization and immunohistochemical
approaches, which can also be performed in human brain tissue
and thereby, this kind of samples contribute to clarify the
findings in culture and animal brains, supporting the significance
of localized mRNAs and the translation machinery in several
pathophysiological contexts. However, postmortem tissue does
not allow mechanistic assessment and cell-compartment isolation
from brain neurons is not possible at clinical stages. Human
studies are thus one of the main challenges in the field of local
protein synthesis.
On the other hand, localized translation research in the
context of pathologies provides new exciting venues for the
development of novel therapeutic targets for nervous system
pathologies although localized strategies should be explored
more in detail. For instance, current technologies do not allow
the knockdown of specific axonal mRNAs without altering the
somatic counterparts. Every effort should be done to develop
new approaches on this matter. Nevertheless, it is worth noting
that local protein synthesis in neurons does not seem to rely
only on the neurons but that glial cells might contribute
to this phenomenon. Interestingly, in the peripheral nervous
system, Schwann cells transfer ribosomes to injured sciatic nerves
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(Court et al., 2008) whereas in the spinal cord, a transference
of ribosome-like particles at the axonal-myelin sheath interface
has suggested (Li et al., 2005). These data point at the possibility
of a novel therapeutic strategy based on modulating glia-neuron
transference instead of interfering directly with translation at
subneuronal compartments. In either case, further research
is still required.
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